Analystreport

Boston Scientific (NYSE: BSX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $36.00 price target on the stock.

Boston Scientific Corporation  (BSX) 
Last boston scientific corporation earnings: 4/29 06:30 am Check Earnings Report
US:NYSE Investor Relations: investors.bostonscientific.com